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Abstract
Purpose: The aim of this retrospective study was to
investigate the efficacy of morphine-augmented hepa-
tobiliary imaging (MAHBI) for diagnosing acute chole-
cystitis (AC).
Methods: Sixty-eight patients (Male:Female = 36:32,
age = 54 ± 17 years) referred for diagnosis of AC by
30-min post-morphine MAHBI after the standard 1-h
imaging were recruited. Non-visualization of gallbladder
on 30-min post-morphine images by visual analysis was
considered positive. Final diagnosis of pathological
examination for all patients was used as the gold
standard.
Results: There was significant correlation of AC and
MAHBI (p < 0.05). There were 45 true positive (TP), 19
false positive (FP), 4 true negative (TN), and no false
negative (FN) cases using gallbladder visualization by
30-min post-morphine as the criteria, with a high false
positive rate of 83%. The sensitivity, specificity, accu-
racy, positive and negative predictive values of MAHBI
in detecting AC were 100%, 17%, 72%, 70%, and 100%,
respectively.
Conclusions:MAHBI is sensitive but may not specific for
diagnosing AC due to the potential pitfall of high false
positive rate. Correlation with other clinical findings is
recommended for optimal patient management.
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Acute cholecystitis (AC) is an acute inﬂammation in the
gallbladder. Acute calculous cholecystitis (ACC) always
starts with persistent obstruction of gallbladder outlet by
a stone impacted in the neck of the gallbladder, Hart-
mann’s pouch, or the cystic duct. As a result, pressure
inside the gallbladder rises, causing rapid distention of
the gallbladder, decreased blood supply, ischemia of the
gallbladder walls, bacterial invasion with acute inﬂam-
mation, and possible perforation. Gallstones are not
found in 5% to 10% of patients with acute cholecystitis
(acute acalculous cholecystitis). The pathogenesis of
acute acalculous cholecystitis (AAC) is not fully under-
stood and probably involves ischemia, biliary stasis with
activation of local bacterial ﬂora, and chemical inﬂam-
mation [1]. Repeated episodes of acute inflammation
may lead to chronic cholecystitis (CC). Gallbladder walls
will become thick, infiltrated with inflammatory cells.
The subsequent development of fibrosis leads to a loss of
contractility of the gallbladder. Hepatobiliary imaging is
considered the procedure of choice for diagnosing AC.
Diagnosis of AC is made when the gallbladder is not seen
for up to 4 h. Morphine-augmentation has been used as
an alternative to delayed imaging to shorten the total
imaging time required to diagnose AC [2]. The entire
study can be terminated in 90 min in contrast to the 4 h
or more with delayed imaging. Previous studies of pa-
tients with suspected AC have indicated that the mor-
phine-augmentation is as useful as, or more useful than,
delayed imaging [2–7]. However, morphine-augmented
hepatobiliary imaging (MAHBI) as well as traditional
delayed imaging are susceptible to false positive results
which, in turn, result in decreased specificity [5, 8–10].
Prolonging post-morphine imaging to reduce false posi-
tive rate has recently been proved effective in a retro-
spective study performed by Tang et al [9]. The aim ofCorrespondence to: Ching-yee Oliver Wong; email: bortau@hotmail.
com
ª The Author(s) 2014. This article is published with open access at Springerlink.com
Published online: 9 January 2014Abdominal
Imaging
Abdom Imaging (2014) 39:467–471
DOI: 10.1007/s00261-013-0067-8
this retrospective study was to reevaluate the efficacy of
MAHBI in detecting AC.
Materials and methods
Demographic and clinical data
The selection criteria were all patients who underwent
surgery with a clinical diagnosis of acute cholecystitis
from January 2010 to September 2011. They all pre-
sented with epigastric or right-upper quadrant abdomi-
nal pain and were sent for hepatobiliary imaging. The
post-morphine part was determined later by nuclear
medicine physicians. There were 68 patients (36 male and
32 female, age = 54 ± 17 years). All patients underwent
surgery within one week of MAHBI. Their images were
analyzed visually and histopathologic results of gall-
bladder were retrospectively reviewed. This study has
been reviewed and approved by the Human Investigation
Committee. Exclusion criteria were (a) Scans were per-
formed to evaluate a disease other than AC. (b) No
pathological proof. (c) No post-morphine part. (d) Pre-
vious cholecystectomy. (e) Acute pancreatitis. (f) Alco-
holism. (g) Sphincterotomy. (h) Taking chronic opiate
pain medications. (i) Total parenteral nutrition. Thirty-
eight patients were excluded because they did not receive
surgery after MAHBI. Two patients were excluded due
to acute pancreatitis.
Imaging protocol
MAHBI was performed 4–6 h after fasting with
185 MBq (5 mCi) of technetium-99 m disofenin using a
large-ﬁeld-of-view c-camera ﬁtted with a low-energy,
parallel-hole collimator. Anterior view hepatic phase
dynamic images were obtained for 30 min followed by
anterior static images at 45, 50, 55, and 60 min post-
radiotracer injection and gallbladder phase dynamic
images were obtained for an additional 30 min. The total
duration of imaging was 90 min. Both phase images were
acquired separately and recorded on a 128 9 128 9 16
computer matrix. After nonvisualization of gallbladder
at 60 min had been conﬁrmed, a booster dose of 74–
111 MBq (2–3 mCi) technetium-99 m disofenin was in-
jected. This was followed by the injection of 0.04 mg of
morphine sulfate per kilogram for 3 min provided that
radiotracer was seen within the small bowel. Cholecys-
tokinin was not used in this examination because it might
induce gallbladder contraction against a contracted
sphincter of Oddi, increasing patient discomfort (Fig. 1).
Imaging interpretation
To avoid interobserver variability, all images were
interpreted carefully by two experienced board-certiﬁed
nuclear medicine physicians without knowledge of the
Fig. 1. Representative true positive morphine-augmented
hepatobiliary imaging. A Hepatobiliary imaging at 60 min after
radiotracer injection. There was no gallbladder visualization
after passage of the radiotracer into the common bile duct and
small bowel. B Hepatobiliary imaging at 30 min after morphine
administration. Even 30 min after morphine administration, the
gallbladder was not seen, indicating acute cholecystitis. The
pathological finding was consistent with acute cholecystitis
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clinical or histopathologic ﬁndings. If two readers’
interpretations were conﬂicting, a third nuclear medicine
physician reviewed the study. Nonvisualization of gall-
bladder by 30-min post-morphine administration was
considered as a positive MAHBI for AC. The results of
image analysis were ﬁnally correlated with the gold
standard of pathological ﬁndings (Fig. 2).
Statistical analysis
Using pathological gold standard, descriptive statistics
were used to describe the basic features of the data in the
study. The chi-square test or the Fisher’s exact test was
used to evaluate associations between categorical vari-
ables. A p-value less than 0.05 was considered significant
in all tests.
Results
Of 68 patients with surgery, 45 patients had AC as de-
ﬁned by neutrophilic inﬁltration, necrosis, hemorrhage,
or edema, 21 patients had CC as deﬁned by lymphocytic
and plasma cell inﬁltration, ﬁbrosis, or wall thickening,
and two patients had adenocarcinoma of gallbladder. If
pathologic features of AC and CC were both seen, the
patient was classiﬁed as AC in this study. Of 45 patients
with AC, 13 (13/45, 29%) patients were AAC and 32 (32/
45, 71%) patients were ACC. Of 21 patients with CC,
only one (1/21, 5%) patient was CAC and the remaining
20 (20/21, 95%) patients were CCC. Gallstones were also
seen in two patients with adenocarcinoma of gallbladder.
Signiﬁcant correlation of AC and MAHBI was observed
(p < 0.05). As shown in Table 1, there were 45 TP, 19
FP, 4 TN, and no FN cases using gallbladder visualiza-
tion by 30-min post-morphine infusion as the criteria.
High false positive rate of 83% (19/23) was observed. The
sensitivity, specificity, accuracy, positive, and negative
predictive values of MAHBI in detecting AC was 100%,
17%, 72%, 70%, and 100%, respectively. Gallstones were
presented in all FP cases (19/19, 100%), while 32 TP cases
(32/45, 71%) were found to have gallstones. Gallstones
were seen more frequently in FP cases than TP cases
(100% vs. 71%, p < 0.05).
Discussion
The reported sensitivity of MAHBI was consistently high
[2, 5–7, 9, 10]; however, some reported specificity was not
as good as sensitivity due to the relatively high false
positive rate [5, 8–10]. However, it is important to keep in
mind that different variations of MAHBI techniques and
different percentage of pathologic-confirmed AC were
included into the analyses, which is statistically subop-
timal. In the current study of 68 patients with histo-
pathologic proof, the sensitivity, specificity, and accuracy
were 100%, 17%, and 72%, respectively. Although there
Fig. 2. Representative true negative morphine-augmented
hepatobiliary imaging. A Hepatobiliary imaging at 60 min after
radiotracer injection. There was no definite gallbladder visu-
alization after passage of the radiotracer into the small bowel.
B Hepatobiliary imaging at 30 min after morphine adminis-
tration. At 30 min after morphine administration, the gall-
bladder was clearly seen, excluding acute cholecystitis. The
pathological finding was chronic cholecystitis
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was perfect sensitivity, the specificity was low. However,
it is likely that the specificity of this examination has
been overestimated by previous researchers, influencing
current operative decisions.
The current results demonstrated considerably low
speciﬁcity of MAHBI. The exact reason is not very clear;
however, selection bias may play a role in this respect. In
other words, the determination of operation by surgeons
will affect the study results. In most centers where this
study was performed, surgeons tended to select patients
with positive MAHBI for operation, and chose conser-
vative treatment for those with negative MAHBI. As a
consequence, there might be less true negative MAHBI
and more false positive MAHBI detected. Fig et al [10]
reported a 69% specificity of MAHBI in patients with
severe illnesses, indicating occurrence of high positive
rate in patients with severe illnesses. In this study, 17 FP
cases (17/19, 89%) had CC, suggesting that CC is prob-
ably the most common cause of FP rate in MAHBI since
we did not intentionally include patients with severe ill-
nesses. More specifically, no concurrent severe illnesses
were found in current study for all FP cases. However,
the result is similar to previously published literatures
using hepatobiliary imaging without morphine augmen-
tation [11–13]. Therefore, most false positive results for
AC are secondary to CC in hepatobiliary imaging whe-
ther morphine is used or not. Previous investigators have
also indicated that rapid biliary-to-bowel transit might
potentially cause false positive MAHBI because of
insufficient radiotracer activity remaining in the liver to
permit visualization of gallbladder post-morphine aug-
mentation despite a patent cystic duct [7]. In the current
study, each patient received a booster dose of 74–
111 MBq (2–3 mCi) technetium-99 m disofenin after
nonvisualization of gallbladder at 60 min had been
confirmed so that rapid biliary-to-bowel transit would
not be a significant issue. Rare cases with potential for
false-positive interpretations include congenital gall-
bladder absence, choledochal cysts, cystic fibrosis,
inflammation within the immediate proximity of the
gallbladder fossa, rupture of a hydatid cyst into biliary
tree, unusually elongated gallbladder that is mistaken for
the bowel, primary or secondary gallbladder neoplasms,
and ceftriaxone therapy [14].
The differences in methodology contribute greatly to
the differences in the reported speciﬁcity of MAHBI. It is
very important to know whether the ﬁnal diagnoses were
conﬁrmed by surgical pathology. The percentage of
pathologic-conﬁrmed AC varies widely. A large majority
of previous studies used both pathology results and
clinical follow up as ﬁnal diagnosis, while this study
adopted only pathology results as ﬁnal diagnosis. Like
many other diseases, the gold standard for diagnosing
AC is pathological examination of the gallbladder. Thus,
we believe that the results of the current study are con-
vincing although the patient number operated on the
negative MAHBI might be small. Nevertheless, the use
of a strict pathological criterion for AC (e.g., transmural
inﬂammatory inﬁltration) might ignore the natural his-
tory of this condition. Cholecystectomy specimen re-
moved for AC often shows telltale evidence of pervious
inﬂammatory episodes of AC, with ﬁbrotic, reparative
processes. Such ﬁbrotic, reparative processes most likely
hinder the development of acute transmural inﬂamma-
tory changes, and patients with AC superimposed on CC
are mislabeled as CC using such a criterion [15]. Patients
with CC are more likely to have gallstones than patients
with AC in the current study. Since CC may be the major
cause of FP MAHBI, it is not surprising to observe more
gallstone disease in FP MAHBI in comparison with TP
MAHBI. It is postulated that in patients with CC, there
is probably stasis of concentrated thick bile in the dis-
eased gallbladder, mainly the cystic duct that precludes
gallbladder visualization. The presence of bile sludge can
only be suggested by gallbladder nonvisualization in
MAHBI.
Inﬂammatory gallbladder disease presents as a clini-
cal and pathologic spectrum which ranges from acute to
subacute to chronic. Distinctions between these entities
often are not clear-cut. AC has been reported to correlate
most closely with nonvisualization on hepatobiliary
imaging but delayed visualization may also be seen. CC
may correlate most closely with delayed visualization but
nonvisualization also occurs as we have demonstrated in
the current study. Such overlap of diseases and ﬁndings
can cause confusion. However, there is agreement in the
literatures that a positive hepatobiliary imaging (nonvi-
sualization or delayed visualization) correlates closely
with cholecystitis (acute, subacute, or chronic). Freitas
and Gulati make a sound argument that CC patients
should undergo cholecystectomy anyway and differenti-
ation from AC may be a moot point. Hence, a false
positive study may not be a deleterious error [12, 14, 16].
Conclusion
MAHBI is sensitive but may not speciﬁc for diagnosing
AC due to the potential pitfall of high false positive rate.
Table 1. Results of morphine-augmented hepatobiliary imaging
Histopathology Visualization of gallbladder within 30-min
post-morphine infusion
Nonvisualization of gallbladder within
30-min post-morphine infusion
Acute cholecystitis 0 45 (32 with gallstones)
Chronic cholecystitis or gallbladder cancer 4 (3 with gallstones) 19 (19 with gallstones)
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It is of paramount importance to determine whether lo-
cal surgical preference is for early surgical intervention or
conservative management followed by scheduled elective
surgeries. Correlation with physical examination, clinical
history, abdominal ultrasound, and laboratory ﬁndings
is highly recommended for optimal patient management.
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